Japanese Journal of Cancer Research · 1990 · 89 citations · 16 references
MedicineInfectious DiseasesOncologyClinical ImmunologyHepatologyTransfusion MedicineAntibody ScreeningAntibody-antigen RecognitionHepatic PathologyHepatobiliary CancerHepatocellular CarcinomaViral HepatitisBlood Transfusion TherapyHepatitis Virus Testing
Antibodies against a possible causative agent of non-A, non-B hepatitis, hepatitis C virus (HCV), in Japanese patients with hepatocellular carcinoma were analyzed using the enzyme-linked immunosorbent assay (ELISA) system from Ortho Diagnostic Systems, Japan. Fifty of 58 cases of hepatitis B virus surface antigen (HBsAg)-negative hepatocellular carcinoma were positive for the antibody (86%) and 8 of 42 cases of HBsAg-positive hepatocellular carcinoma were positive (19%). Among patients with HBsAg-negative hepatocellular carcinoma, the prevalence of the antibody was greater among those who had received a blood transfusion (97%) than among those with no history of transfusion (70%). Only 3 of 54 patients with cancers other than hepatocellular carcinoma were found to be antibody-positive (5.6%) and all three patients had a history of blood transfusion. These results show a close relationship between the presence of anti-HCV antibody and HBsAg-negative hepatocellular carcinoma in Japan.
16
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Qui‐Lim Choo, George Kuo, Amy J. Weiner et al. · Science · 1989 · 6.9K citations
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
George Kuo, Q L Choo, Harrison Alter et al. · Science · 1989 · 3.4K citations
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
R. Palmer Beasley, Chia‐Chin Lin, Lu‐Yu Hwang et al. · The Lancet · 1981 · 2.9K citations
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
L. Viladomiu, Antonio González, M Roget et al. · The Lancet · 1989 · 900 citations